Effect of Nilotinib on Bleomycin-Induced Acute Lung Injury and Pulmonary Fibrosis in Mice

BACKGROUND: The tyrosine kinase inhibitor imatinib mesylate was developed as an inhibitor of the kinase activity of BCR-ABL. However, imatinib also has potent inhibitory activity against the platelet-derived growth factor receptor (PDGFR). Nilotinib is approved for treating patients with chronic mye...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Respiration
Главные авторы: Rhee, Chin Kook, Lee, Sang Haak, Yoon, Hyung Kyu, Kim, Seok Chan, Lee, Sook Young, Kwon, Soon Suk, Kim, Young Kyoon, Kim, Kwan Hyoung, Kim, Tae Jung, Kim, Jin Woo
Формат: Artigo
Язык:Inglês
Опубликовано: S. Karger AG 2011
Предметы:
Basic Science Investigations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7068797/
https://ncbi.nlm.nih.gov/pubmed/21659722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000327719
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы